Single-session emotion regulation training for Cardiovascular Diseases

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Southern Mississippi, Hattiesburg, MS
Cardiovascular Diseases+6 More
Single-session emotion regulation training - Behavioral
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial will investigate whether a single session of emotion regulation training can reduce cardiovascular disease risk in young adults with depression living in Southern Mississippi. Before and after the skills training session, participants will supply several biological metrics tied to CVD risk: resting HRV, inflammation (measured via c-reactive protein [CRP]), and blood pressure. Single-session emotion regulation training is being used to treat cardiovascular diseases. This type of training has previously been approved by the FDA for a different condition. All patients in this trial will be receiving the training, and no placebo will be given.

Eligible Conditions

  • Cardiovascular Diseases
  • heart rate
  • Major Depressive Disorder (MDD)
  • Inflammation
  • Blood Pressures

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Cardiovascular Diseases

Study Objectives

5 Primary · 3 Secondary · Reporting Duration: Change from prior to the single-session emotion regulation training to immediately after and 1-week after

Change from prior to the single-session emotion regulation training to immediately after and 1-week after
Change in C-reactive protein (CRP)
Change in Center for Epidemiological Studies - Depression Scale (CESD)
Change in Diastolic Blood Pressure
Change in Difficulties with Emotion Regulation Scale (DERS)
Change in Emotion Regulation Questionnaire, Reappraisal subscale (ERQ-R)
Change in Experiences Questionnaire - Decentering (EQ-D)
Change in Resting Heart Rate Varability (HRV)
Change in Systolic Blood Pressure

Trial Safety

Safety Progress

1 of 3

Other trials for Cardiovascular Diseases

Trial Design

1 Treatment Group

Intervention Arm
1 of 1
Experimental Treatment

25 Total Participants · 1 Treatment Group

Primary Treatment: Single-session emotion regulation training · No Placebo Group · N/A

Intervention Arm
Behavioral
Experimental Group · 1 Intervention: Single-session emotion regulation training · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change from prior to the single-session emotion regulation training to immediately after and 1-week after
Closest Location: University of Southern Mississippi · Hattiesburg, MS
Photo of mississippi 1Photo of mississippi 2Photo of mississippi 3
2020First Recorded Clinical Trial
1 TrialsResearching Cardiovascular Diseases
2 CompletedClinical Trials

Who is running the clinical trial?

University of Southern MississippiLead Sponsor
9 Previous Clinical Trials
2,984 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You must be able to speak and read English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.